See every side of every news story
Get Started
SubscribeLogin
Social Media
Boxing
Natural Disasters
WWE
Instagram
Artificial Intelligence
All Elite Wrestling
Donald Trump
Music
Cryptocurrency
Israel-Hamas Conflict
Tennis
Published • loading... • Updated

HIV Prevention Vaginal Ring Withdrawn From FDA Consideration

Summary by Ground News
The International Partnership for Microbicides pulled its application for FDA approval for the pre-exposure prophylaxis (PrEP) ring. That leaves cisgender women with two HIV prevention options. The daily pill, first approved in 2012, is now generic but previously sold as Truvada.

1 Articles

All
Left
Center
Right
MedscapeMedscape

HIV Prevention Vaginal Ring Withdrawn From FDA Consideration

One year after the World Health Organization recommended a vaginal ring to protect women from HIV following years of research — some done in the US — the ring will not be coming to US clinics. Here's why.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States on Tuesday, January 25, 2022.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical icon

Medical

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal